The remaining study analysed the effects of a combined running exercise trial.
We included 112 outpatients with major depression from an exercise trial and 57 healthy controls.
Sixty min of treadmill running at ∼70% of maximum oxygen uptake was performed at 0 1 h in the fasted exercise trial and 4 5 h in the postprandial exercise trial.
The exercise trial comprised of 10 × 10 s running sprints, interspersed by 50 s active recovery (walking).
The remaining three studies reported significant differences from baseline to post-exercise within the exercise trial [16, 66] and between [16, 50, 66] exercise and control conditions.
Gait analysis, radiographs, ultrasound and serum insulin and glucose concentrations were performed prior to the exercise trial and at each time point.
Twenty-seven men and women participated in two sessions in random order: 60-min walking on the treadmill (exercise trial; EX) or seated rest (control trial; CON).
The Erlangen Fitness Osteoporosis Prevention Study: a controlled exercise trial in early postmenopausal women with low bone density first-year results.
The following data was extracted: participant numbers, age, gender, body mass index (BMI), training status, VO2max, exercise trial details and pre- and post-exercise values for the variables of interest (IL-6, CRP and neutrophil counts).
The aim of this report is to describe the purpose, study design, methods, and recruitment results of the courage trial, a National Cancer Institute (NCI) sponsored, phase II, randomized, dose response exercise trial among colon cancer survivors.
We evaluated weight loss response to 16 months of supervised exercise (45 min/day, 5 days/week, 75% heart-rate-reserve) in sedentary, overweight/obese participants without energy restriction in the Midwest Exercise Trial (MET1).
